Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006
- 2 June 2009
- Vol. 27 (27) , 3553-3560
- https://doi.org/10.1016/j.vaccine.2009.03.063
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6CThe Journal of Infectious Diseases, 2008
- Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005The Journal of Infectious Diseases, 2008
- Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004The Journal of Infectious Diseases, 2007
- Discovery of a New Capsular Serotype (6C) within Serogroup 6 ofStreptococcus pneumoniaeJournal of Clinical Microbiology, 2007
- Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-ResistantStreptococcus pneumoniaeNew England Journal of Medicine, 2006
- Progress in the prevention of pneumococcal infectionCMAJ : Canadian Medical Association Journal, 2005
- Estimates of world-wide distribution of child deaths from acute respiratory infectionsPublished by Elsevier ,2002
- Characterization of a Genetic Element Carrying the Macrolide Efflux Gene mef (A) in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2000
- The burden of pneumococcal disease among adults in developed and developing countries: what is and is not knownVaccine, 1999
- Induction of Ribosome Methylation in MLS-ResistantStreptococcus pneumoniaeby Macrolides and KetolidesMicrobial Drug Resistance, 1999